- Home
- ELS vs ASND Comparison
ELS vs ASND Comparison
Compare ELS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELS | ASND |
|---|---|---|
| Founded | 1992 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 15.0B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ELS | ASND |
|---|---|---|
| Price | $59.44 | $246.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 22 |
| Target Price | $68.05 | ★ $304.69 |
| AVG Volume (30 Days) | ★ 1.9M | 660.7K |
| Earning Date | 10-20-2026 | 11-11-2026 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | ★ 2.55 | N/A |
| EPS | ★ 0.56 | N/A |
| Revenue | ★ $1,531,382,000.00 | N/A |
| Revenue This Year | $3.02 | $90.79 |
| Revenue Next Year | $3.61 | $46.19 |
| P/E Ratio | $108.96 | ★ N/A |
| Revenue Growth | ★ 0.34 | N/A |
| 52 Week Low | $57.46 | $188.07 |
| 52 Week High | $69.00 | $282.15 |
Technical Indicators
Market Signals| Indicator | ELS | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 61.64 |
| Support Level | $57.46 | $240.10 |
| Resistance Level | $64.36 | $249.89 |
| Average True Range (ATR) | 1.42 | 5.76 |
| MACD | 0.21 | 3.17 |
| Stochastic Oscillator | 40.98 | 97.58 |
Price Performance
Historical ComparisonAbout ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company has a portfolio of 453 properties across the US with a higher concentration in the Sun Belt; 38% of its properties are in Florida, 11% in Arizona, and 10% in California. Equity Lifestyle targets owning properties in attractive retirement destinations. More than 70% of the company's properties are either age-restricted or have an average resident age over 55.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.